UPDATE: Geneart Boards Recommend Acceptance of Life Tech Acquisition Bid | GenomeWeb

This article has been updated to include the total purchase price of the acquisition.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Geneart today said that its Management Board and Supervisory Board have recommended that shareholders accept Life Technologies' bid to acquire all of the firm's outstanding shares.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.